Pacific Biosciences of California Inc., the much-talked-about Menlo Park developer of a third-generation DNA sequencing machine, said it is shipping its first commercial product.
PacBio (NASDAQ: PACB) formally enters a fast-moving field that includes Life Technologies Corp. (NASDAQ: LIFE) in Fremont. PacBio said, however, that its RS system puts results in the hands of researchers in less than a day, compared to a week with many sequencing machines on the market today.
No comments:
Post a Comment